PP
GILD icon

Pegasus Partners’s Gilead Sciences GILD Stock Holding History

Pegasus Partners’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q1 		– Sell
-18,522
Closed -$1.33M – 149
2017
Q4 		$1.33M Sell
18,522
-329
-2% -$25K 0.27% 100
2017
Q3 		$1.53M Sell
18,851
-2,345
-11% -$179K 0.35% 84
2017
Q2 		$1.5M Buy
21,196
+2,472
+13% +$164K 0.4% 83
2017
Q1 		$1.27M Buy
18,724
+4,980
+36% +$350K 0.52% 51
2016
Q4 		$984K Sell
13,744
-14,003
-50% -$1.04M 0.43% 62
2016
Q3 		$2.19M Buy
27,747
+1,552
+6% +$126K 1.04% 27
2016
Q2 		$2.19M Buy
26,195
+1,165
+5% +$103K 1.13% 28
2016
Q1 		$2.3M Buy
25,030
+18,635
+291% +$1.68M 1.25% 24
2015
Q4 		$647K Buy
+6,395
New +$665K 0.32% 61

Other funds holding GILD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Parnassus Investments
Parnassus Investments San Francisco, California $34.1B AUM 20.22% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Pegasus Partners's GILD Position: Q1 2018 in Review

Pegasus Partners sold out of Gilead Sciences (GILD) in Q1 2018, closing a stake of 18,522 shares — an estimated $1.33M sold.

Pegasus Partners first reported a position in GILD in Q4 2015 and held it in 9 quarters. The position peaked at $2.3M in Q1 2016. 1,563 funds tracked by Wall St. Rank hold GILD as of Q1 2018.

  • Pegasus Partners reported no remaining Gilead Sciences position as of Q1 2018 after selling out during the quarter.
  • Pegasus Partners sold 18,522 Gilead Sciences shares in Q1 2018, an estimated $1.33M.
  • Pegasus Partners first reported a position in Gilead Sciences in Q4 2015 and held it in 9 quarters.
  • Pegasus Partners's Gilead Sciences position peaked at $2.3M in Q1 2016.
  • 1,563 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2018.

Based on Pegasus Partners's 13F filing for Q1 2018, filed 9 May 2018.